-+ 0.00%
-+ 0.00%
-+ 0.00%

Heron Therapeutics gets Nasdaq notice after shares trade below $1 bid price requirement

PUBT·06/25/2026 21:01:06
Listen to the news
Heron Therapeutics gets Nasdaq notice after shares trade below $1 bid price requirement
  • Heron Therapeutics received a Nasdaq notice for failing the $1 minimum bid price rule on Nasdaq Capital Market.
  • Shares closed below $1 for 30 straight sessions from May 12, 2026 to June 24, 2026.
  • Nasdaq granted until Dec. 22, 2026 to regain compliance, typically requiring at least 10 consecutive sessions at $1 or higher.
  • Listing status remains unchanged for now, but failure to cure could trigger delisting proceedings.
  • A second 180-day window may be available, potentially requiring a reverse stock split to restore compliance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heron Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-282988), on June 25, 2026, and is solely responsible for the information contained therein.